Drug repurposing: a better approach for infectious disease drug discovery?
作者： G Lynn Law , Jennifer Tisoncik-Go , Marcus J Korth , Michael G Katze , None
DOI: 10.1016/J.COI.2013.08.004
关键词:
摘要: … influenza, the newly discovered Middle Eastern Respiratory … both the time and cost for infectious diseases drug discovery. … an effort to improve effective drug discovery. To illustrate the …
sci-hub.se 参考文章(29)
Hongkang Mei, Tian Xia, Gang Feng, Jason Zhu, Simon M. Lin, Yang Qiu, Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases. Drug Discovery Today. ,vol. 17, pp. 1208- 1216 ,(2012) , 10.1016/J.DRUDIS.2012.06.015
Y. A. Lussier, J. L. Chen, The Emergence of Genome-Based Drug Repositioning Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3001512
Jason E McDermott, Deborah L Diamond, Courtney Corley, Angela L Rasmussen, Michael G Katze, Katrina M Waters, Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis BMC Systems Biology. ,vol. 6, pp. 28- 28 ,(2012) , 10.1186/1752-0509-6-28
Xin He, Yu Wang, Jinhong Zhu, Mohammed Orloff, Charis Eng, Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling Cancer Letters. ,vol. 301, pp. 168- 176 ,(2011) , 10.1016/J.CANLET.2010.11.012
Laura K. Stewart, Jeff L. Soileau, David Ribnicky, Zhong Q. Wang, Ilya Raskin, Alexander Poulev, Martin Majewski, William T. Cefalu, Thomas W. Gettys, Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet Metabolism-clinical and Experimental. ,vol. 57, ,(2008) , 10.1016/J.METABOL.2008.03.003
Qinghe Chen, Suthakar Ganapathy, Karan P Singh, Sharmila Shankar, Rakesh K Srivastava, None, Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells PLoS ONE. ,vol. 5, pp. e15288- ,(2010) , 10.1371/JOURNAL.PONE.0015288
Laurence Josset, Julien Textoris, Béatrice Loriod, Olivier Ferraris, Vincent Moules, Bruno Lina, Catherine N'Guyen, Jean-Jacques Diaz, Manuel Rosa-Calatrava, Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals PLoS ONE. ,vol. 5, pp. e13169- ,(2010) , 10.1371/JOURNAL.PONE.0013169
Zikai Wu, Yong Wang, Luonan Chen, None, Network-based drug repositioning Molecular BioSystems. ,vol. 9, pp. 1268- 1281 ,(2013) , 10.1039/C3MB25382A
Charles Ansong, Alexandra C. Schrimpe-Rutledge, Hugh D. Mitchell, Sadhana Chauhan, Marcus B. Jones, Young-Mo Kim, Kathleen McAteer, Brooke L. Deatherage Kaiser, Jennifer L. Dubois, Heather M. Brewer, Bryan C. Frank, Jason E. McDermott, Thomas O. Metz, Scott N. Peterson, Richard D. Smith, Vladimir L. Motin, Joshua N. Adkins, A multi-omic systems approach to elucidating Yersinia virulence mechanisms Molecular BioSystems. ,vol. 9, pp. 44- 54 ,(2013) , 10.1039/C2MB25287B
Laurence Josset, Vineet D. Menachery, Lisa E. Gralinski, Sudhakar Agnihothram, Pavel Sova, Victoria S. Carter, Boyd L. Yount, Rachel L. Graham, Ralph S. Baric, Michael G. Katze, Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus mBio. ,vol. 4, ,(2013) , 10.1128/MBIO.00165-13